Japanese mid-size drugmaker Otsuka Pharmaceutical announced that it has entered into an exclusive worldwide licensing ...

Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

The Aventa FusionPlus test incorporates 3D genomics technology, leveraging preservation of the spatial proximity of fused and ...

You were born special,” Heather Horne told her 3-year-old daughter. “You were born without bone, and the doctor is gonna put ...

Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders On track to report topline data from the RewinD-LB ...

They hope to continue exploring ways to improve treatment outcomes for patients with soft tissue sarcomas. Sarcoma is a rare type of cancer that develops in connective tissues, such as muscle, bone, ...

Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...

The JMM, Congress and RJD are fused Diwali crackers now. BJP is a mighty rocket that alone will take Jharkhand to newer heights," PTI quoted the minister. Singh said JMM meant 'Jamkar Malai Maro ...

Adaptimmune Therapeutics is prepping for another FDA submission after 42% of patients with sarcoma responded to the company's investigational cell therapy in a pivotal phase 2 trial. The primary ...